NASDAQ: CCTSCactus Acquisition Corp 1 Ltd Stock
$10.92-0.09 (-0.82%)
Updated Dec 8, 2023
CCTS Price
$10.92
Fair Value Price
$10.93
Market Cap
$34.53M
52 Week Low
$10.23
52 Week High
$12.52
P/E
-27.3x
P/B
-6.61x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
$2.21M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-1.01
Operating Cash Flow
$3M
Beta
0
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
CCTS Overview
Cactus Acquisition Corp. 1 Ltd. is a "blank check" company formed to effect mergers, share exchanges, asset acquisitions, stock purchases, recapitalizations, reorganizations, or related business combinations. It targets businesses in the technology-based healthcare sector. It is sponsored by Cactus Healthcare Management LP, a Delaware limited partnership. Cactus Acquisition was incorporated in 2021 and is based in Cranbury, NJ.
Zen Score
–
Industry Average (8)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how CCTS scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
CCTS ($10.92) is undervalued by 0.07% relative to our estimate of its Fair Value price of $10.93 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
CCTS ($10.92) is not significantly undervalued (0.07%) relative to our estimate of its Fair Value price of $10.93 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
CCTS is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more CCTS due diligence checks available for Premium users.
Be the first to know about important CCTS news, forecast changes, insider trades & much more!
CCTS News
Valuation
CCTS fair value
Fair Value of CCTS stock based on Discounted Cash Flow (DCF)
Price
$10.92
Fair Value
$10.93
Undervalued by
0.07%
CCTS ($10.92) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
CCTS ($10.92) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
CCTS is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
CCTS price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-27.3x
Industry
31.16x
Market
31.32x
CCTS price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-6.61x
Industry
-14.58x
CCTS's financial health
Profit margin
Revenue
$0.0
Net Income
$147.0k
Profit Margin
0%
CCTS's Earnings (EBIT) of $2.21M... subscribe to Premium to read more.
Interest Coverage Financials
Assets to liabilities
Assets
$24.7M
Liabilities
$5.3M
Debt to equity
-1.01
CCTS's short-term liabilities ($849.00k) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CCTS's long-term liabilities ($4.43M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CCTS's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
CCTS's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$101.0k
Investing
$0.0
Financing
$200.0k
CCTS's operating cash flow ($2.81M)... subscribe to Premium to read more.
Debt Coverage Financials
CCTS vs Shell Company Stocks
Cactus Acquisition 1 Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.